Exclusive

Publication

Byline

CAT 2026: Extended registration window closes today at iimcat.ac.in, check admit card and exam date

India, Sept. 22 -- The Indian Institutes of Management will close the extended registration window for CAT 2026 on September 22, 2026. All candidates who have not yet applied for the Common Admission ... Read More


Iran President Pezeshkian en route to UNGA warns against regional oppression, calls for global trust

New York, Sept. 22 -- Iranian President Masoud Pezeshkian made strong remarks emphasising global awareness against regional oppression and advocating for international peace while travelling to New Yo... Read More


SKUAST-K seminar highlights role of millets in health, climate resilience

Srinagar, Sept. 22 -- Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir (SKUAST-K), in collaboration with the Sher-i-Kashmir Institute of Medical Sciences (SKIMS) and Kheti ... Read More


Rajasthan civic polls: BJP wins Bikaner, Ajmer Deputy Mayor posts

Jaipur, Sept. 22 -- The Bharatiya Janata Party (BJP) secured the Deputy Mayor posts in Bikaner and Ajmer Municipal Corporations following the results being declared of the closely contested elections.... Read More


Top leader meets with Vietnamese community in US

New York, Sept. 22 -- General Secretary of the Communist Party of Vietnam Central Committee and President To Lam, together with the high-ranking Vietnamese delegation, attended a cultural event and me... Read More


Singapore Clinical Trial: Characteristics and durability of immune response to fractional dose compared to standard dose Yellow Fever vaccine: a pilot open-label 1:1 randomized non-inferiority/estimation trial in adults in Singapore

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'Characteristics and durability of immune response to fractional dose compared to standard dose Ye... Read More


Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More


Singapore Clinical Trial: A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (NEBULA-1)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More


Singapore Clinical Trial: The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA... Read More


Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More